SCHEMBL4841497

SCHEMBL4841497

C=CCC(C(=O)N(C1CCCC1)[C@@H](C=C)c1ccccc1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.37
▸ GAA P10253 2/20 0.37
▸ POLB P06746 4/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ APEX1 P27695 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CCR5 P51681 1/20 0.35
▸ CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4838082 1.00 ALDH1A1 (0.37) ALDH1A1GAAPOLBHSD17B10KDM4E
SCHEMBL4838845 0.82 ALDH1A1 (0.37) ALDH1A1GAAPOLBHSD17B10KDM4E
SCHEMBL14254602 0.82 ALDH1A1 (0.37) ALDH1A1GAAPOLBHSD17B10KDM4E
SCHEMBL4841290 0.78 ALDH1A1 (0.44) ALDH1A1GAAPOLBHSD17B10KDM4E
SCHEMBL14254608 0.78 ALDH1A1 (0.44) ALDH1A1GAAPOLBHSD17B10KDM4E
SCHEMBL4845270 0.77 GAA (0.39) ALDH1A1GAAPOLBHSD17B10KDM4E
SCHEMBL4841502 0.75 ALDH1A1 (0.36) ALDH1A1GAAPOLBHSD17B10KDM4E
SCHEMBL14254615 0.75 ALDH1A1 (0.36) ALDH1A1GAAPOLBHSD17B10KDM4E
SCHEMBL14254630 0.75 POLB (0.33) ALDH1A1GAAPOLBHSD17B10KDM4E
SCHEMBL14254634 0.72 TNF (0.42) ALDH1A1POLBTP53L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342007-B2 Lactams and uses thereof ASTRAZENECA AB (SE) 2008-03-11 — — US disclosed
US-7342007-B2 Lactams and uses thereof ASTRAZENECA AB (SE) 2008-03-11 — — US disclosed
US-7342007-B2 Lactams and uses thereof ASTRAZENECA AB (SE) 2008-03-11 — — US disclosed
US-20060183732-A1 Novel lactams and uses thereof ASTRAZENECA AB (SE) 2006-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183732-A1 Novel lactams and uses thereof BACE1, BACE2, APP ALDH1A1 2419/4885GAA 38/4885POLB 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback